Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis

Documenti analoghi

• Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts
  di: Shan Meng, et al.
  Pubblicazione: (2026-06-01)
• A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
  di: Elena Elli, et al.
  Pubblicazione: (2012-03-01)
• A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
  di: Elena Elli, et al.
  Pubblicazione: (2012-01-01)
• Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine
  di: Eri Takada, et al.
  Pubblicazione: (2024-02-01)
• Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis
  di: Frontiers Production Office
  Pubblicazione: (2023-05-01)